反复接受高剂量CT检查患者的器官剂量与癌症风险评估
本研究纳入累积有效剂量≥100 mSv的8956例患者,按年龄和性别分层,用蒙特卡罗方法估算27个器官的剂量,并基于BEIR VII相对风险模型估算终生归因癌症死亡风险。结果显示多数器官剂量超过100 mGy,部分器官≥200 mGy;16-44岁队列的终生归因癌症死亡风险中位数为男性每100人0.6-0.7例、女性0.8例,且55-74岁风险不可忽视。
要点
- 累积有效剂量≥100 mSv的患者中,胃和肝脏中位器官剂量超过200 mGy。
- 肺、乳腺、结肠、红骨髓、膀胱、食管、睾丸、卵巢和皮肤剂量为100-200 mGy。
- 16-44岁患者终生归因癌症死亡风险中位数男性为每100人0.6-0.7例,女性为0.8例。
核心结论
- 大多数器官剂量超过100 mGy,部分器官≥200 mGy,伴随不可忽视的终生归因癌症死亡风险。
研究设计与样本
- 回顾性队列研究,纳入8956例累积有效剂量≥100 mSv的患者,按年龄和性别分层;采用蒙特卡罗方法估算27个器官剂量,基于BEIR VII相对风险模型估算终生归因癌症死亡风险。
诊断标准与关键数值
- 累积有效剂量≥100 mSv为纳入标准。
- 胃和肝脏中位器官剂量超过200 mGy。
- 肺、乳腺、结肠、红骨髓、膀胱、食管、睾丸、卵巢和皮肤器官剂量为100-200 mGy。
- 甲状腺和唾液腺剂量为45-69 mGy,但各器官平均剂量均超过100 mGy。
- 16-44岁队列终生归因癌症死亡风险中位数:男性每100人0.6-0.7例,女性每100人0.8例。
临床应用与阅片要点
- 对反复接受CT检查且累积有效剂量≥100 mSv的患者,可参考本研究估算的器官剂量和终生归因癌症死亡风险。
- 55-74岁患者的终生归因癌症死亡风险并不比年轻患者低几个数量级,作者认为该年龄组风险不可忽视。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To estimate cumulative organ doses and age- and gender-stratified cancer mortality risks in patients undergoing recurrent computed tomography (CT) exams.
METHODS: Cohorts of patients who received cumulative effective dose ≥ 100 mSv were stratified into age and gender groups. Organ doses of 27 organs using Monte Carlo methods were available, and the relative risk model from the Biological Effects of Ionizing Radiation VII (BEIR VII) was used to estimate lifetime attributable cancer mortality risks (LACMR).
RESULTS: Out of the 8956 patients, 6.7% were 16-44 years of age, with median organ doses higher than 200 mGy for stomach and liver, whereas organ doses for nine organs, which included lungs, breasts, colon, red bone marrow, urinary bladder, esophagus, testicles, ovaries, and skin were between 100 and 200 mGy. Thyroid and salivary glands had smaller doses in the range of 45-69 mGy, but the mean dose for each organ was over 100 mGy. The age- and gender-specific median LACMR for the 16-44-years cohort was 0.6 to 0.7 deaths per 100 individuals for males, and 0.8 for females. The mortality estimated figures were highest for patients 16-54 years with slightly lower values for older age groups. Except for the highest age bracket of 75-84 years, the LACMR values for 55-74 years are not lower by orders of magnitude, and thus one cannot ignore risks in this age group.
CONCLUSIONS: Organ doses over 100 mGy for most organs and for some organs ≥ 200 mGy with unignorable associated lifetime attributable cancer mortality rates were found.
引用
- Zewde, Ria, Rehani, et al. Organ doses and cancer risk assessment in patients exposed to high doses from recurrent CT exams. Eur J Radiol. 2022. PMID: 35217250. doi:10.1016/j.ejrad.2022.110224
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。